Century Therapeutics, Inc. (IPSC) Stock Analysis & Investment Frameworks
Century Therapeutics, Inc. (IPSC) stock analysis on Invetso. Review Century Therapeutics, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Century Therapeutics, Inc. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Century Therapeutics, Inc. Key Financial Metrics
- Market Cap: $291.53M
- Revenue: $109.16M
- ROE: -52.76%
- ROIC: -43.66%
- Dividend Yield: N/A
About Century Therapeutics, Inc.
Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's foremost clinical program is CNTY-101, an allogeneic, induced pluripotent stem cell (iPSC)-derived CAR-iNK cell therapy. This therapy is specifically designed to target CD19 in patients with B-cell lymphoma that has relapsed or proven refractory to previous treatments. In addition to its lead candidate, the company's robust pipeline features several other therapeutic assets: CNTY-103: A CAR-iNK candidate aimed at CD133 + EGFR for recurrent glioblastoma. CNTY-102: A CAR-iT therapy targeting CD19 + CD79b, intended for relapsed or refractory B-cell lymphoma and other B-cell cancers. CNTY-104: A multi-specific CAR-iT or CAR-iNK candidate in development for acute myeloid leukemia. CNTY-106: Another multi-specific CAR-iNK or CAR-iT candidate for multiple myeloma. Established in 2018, Century Therapeutics, Inc. is based in Philadelphia, Pennsylvania.
Century Therapeutics, Inc. Investment Frameworks
Invetso analyzes Century Therapeutics, Inc. (IPSC) across the following frameworks:
- Century Therapeutics, Inc. 10Y Growth Potential
- Century Therapeutics, Inc. Scenario Analysis
- Century Therapeutics, Inc. Risks & Opportunities
- Century Therapeutics, Inc. Economic Moat
- Century Therapeutics, Inc. Business Model
- Century Therapeutics, Inc. Management
- Century Therapeutics, Inc. SWOT Analysis
- Century Therapeutics, Inc. Porter's 5 Forces
- Century Therapeutics, Inc. PESTLE Analysis
- Century Therapeutics, Inc. ESG Analysis